Chimera Investment Corporation Ne.../ US16934Q2084 /
21/05/2024 22:10:00 | Var. 0.00 | Volume | Denaro01:50:23 | Lettera01:50:23 | Max | Min |
---|---|---|---|---|---|---|
4.39USD | 0.00% | 1.34 mill. Fatturato: 5.07 mill. |
4.35Quantità in denaro: 100 | 4.65Quantità in lettera: 1,200 | 4.44 | 4.36 |
Newsfile Corp
10:52
Myco Secures 2-Year Deal for 6 ICC Tournaments in Pakistan, Teams Up with Willow TV in North America
GlobeNewswire
10:30
Metasphere Labs Shares Industry Developments Signaling Major Advancements in Tokenized Real World As...
GlobeNewswire
10:00
COUNSLR EXPANDS INTO RHODE ISLAND, PARTNERING WITH BRISTOL WARREN REGIONAL SCHOOL DISTRICT TO INCREA...
GlobeNewswire
10:00
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for...
GlobeNewswire
10:00
Questex Unveils Hotel Management’s Tête-à-Tech: Elevating Curated Connections at The Annual Hospital...
GlobeNewswire
10:00
Ecliptic Technology and Bottomline Redefine Global Expert Management for Insurers
GlobeNewswire
10:00
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated...
GlobeNewswire
10:00
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00
EXAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Exscientia p.l.c. Investors wi...
GlobeNewswire
10:00
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00
GL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Globe Life Inc. Investors with S...
GlobeNewswire
10:00
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Inves...